Adam Davidson, CEO of Trident Royalties, discusses offtake milestones and catalysts to boost FY24. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,400.00
Bid: 12,398.00
Ask: 12,400.00
Change: 68.00 (0.55%)
Spread: 2.00 (0.016%)
Open: 12,350.00
High: 12,408.00
Low: 12,314.00
Prev. Close: 12,332.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

EC chief warns Astra must honour contract before exporting doses

Fri, 26th Mar 2021 05:59

(Alliance News) - The European Commission president has warned AstraZeneca PLC that it must "honour" its vaccine contract with the bloc before exporting doses elsewhere in the world.

Ursula von der Leyen urged "transparency" from other countries, but did not confirm if the EU would bring in tougher export restrictions on coronavirus jabs, amid a row over supplies with the British-Swedish pharmaceutical giant.

However, she acknowledged that worldwide supply chains needed to remain "intact" for vaccine production, while some European leaders appeared optimistic that the UK and EU could soon resolve their dispute over supplies.

Elsewhere, UK Prime Minister Boris Johnson sought to calm fears over the possible introduction of coronavirus certificates after publicans criticised his suggestion that it may be up to landlords to decide to request proof of vaccination in venues.

Just days after the prime minister flagged tougher measures to prevent Covid-19 variants being transmitted from Europe, the Telegraph reports the government is planning to implement a mass testing regime for lorry drivers arriving in the UK.

Earlier, addressing a Brussels press conference following a meeting of the European Council on Thursday, von der Leyen said she had "no knowledge" of the UK exporting jabs, while 77 million doses had been exported to 33 countries by the EU so far.

It came after the European Commission set out a tougher regime to stem supplies of jabs to nations faring better in the pandemic as the bloc's states faced a third wave of cases.

von der Leyen told reporters: "Companies have to honour their contract to the EU before they export to other regions in the world. This is of course the case with AstraZeneca.

"I think it is clear that the company [AstraZeneca] has to catch up and honour the contract it has with the EU member states before it can engage again in exporting vaccines."

She added: "We have worldwide supply chains that have to be intact and it is of the utmost importance that we get back to an attitude of openness."

Asked about how many vaccines the UK had exported, von der Leyen told reporters: "I have no knowledge so far of UK exports, perhaps I am mistaken and waiting for their transparency."

Following the summit, Belgian Prime Minister Alexander de Croo said that he believed the EU's dispute with the UK over vaccine supplies "can be resolved" as he referred to a phone call with Johnson last week.

"We think that the discussion we have with the UK can be resolved based on good agreements," de Croo told a Brussels press conference.

Striking a similar tone, Dutch Prime Minister Mark Rutte said that he was "cautiously optimistic" that divisions between the UK and the EU could be resolved.

"I think that on Saturday or soon after, they could come to an agreement which would be very helpful because we are friends, the UK and the rest of Europe, and we need each other," he told reporters.

But leaders appeared to be divided on the issue following the summit, with French president Emmanuel Macron insisting that the EU is "no longer naive" with its export controls tool.

It came after Johnson acknowledged the "moral complexities" around a domestic coronavirus certificate and suggested that it might only be possible to introduce one after all adults had been offered a vaccine at the end of July.

The government will say more on the possible use of Covid status certificates in early April, which could be based on whether people have developed antibodies through infection, as well as vaccinations and negative tests.

But landlords rejected their use after the PM's earlier suggestion it could be up to them to decide whether to screen customers' certificates on entry.

A mobile phone app which features a scannable QR code could be used to provide a virtual coronavirus certificate for entrance into pubs, clubs and restaurants, according to the Daily Mail.

Measures to implement Johnson's "road map" out of lockdown, which will see England's restrictions eased in a series of stages over the coming months, were passed without a vote.

But a series of Tory MPs refused to back a six-month extension to emergency powers contained in the Coronavirus Act after Health Secretary Matt Hancock was unable to say whether they would definitely expire after that.

Some 76 MPs voted to oppose the extension of the laws, although the measure passed with a majority of 408.

source: PA

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
11 Apr 2024 07:20

AstraZeneca to hike 2024 dividend by 7%

(Sharecast News) - Biopharma giant AstraZeneca has announced that it will increase its annual dividend by 7%, which the board said demonstrates its confidence in the company's performance and cash generation.

Read more
8 Apr 2024 08:36

TOP NEWS: AstraZeneca hails neurological data for Ultomiris, Soliris

(Alliance News) - AstraZeneca PLC on Monday said long-term data in generalised myasthenia gravis will underscore the "vital role" of its Ultomiris and Soliris antibodies in the treatment landscape.

Read more
8 Apr 2024 07:43

LONDON BRIEFING: Astra hails neurology data; CVS flags cyberattack

(Alliance News) - London's FTSE 100 is called to open a touch higher on Monday, ahead of an interest rate decision in the eurozone and a US inflation reading later in the week.

Read more
8 Apr 2024 07:02

AstraZeneca's Enhurtu cancer gets US green light for adult patients

(Sharecast News) - AstraZeneca and Daiichi Sankyo's Enhertu cancer drug has been approved in the US for adult patients with unresectable or metastatic solid tumours who have received prior systemic treatment and have no satisfactory alternative options.

Read more
8 Apr 2024 06:53

TOP NEWS: AstraZeneca's, Daiichi's Enhertu receives US FDA approval

(Alliance News) - AstraZeneca PLC and Daiichi Sankyo Co Ltd on Saturday announced that the US Food & Drug Administration has approved their cancer drug conjugate for patients with metastatic HER2-positive solid tumours.

Read more
5 Apr 2024 09:42

AstraZeneca makes "breakthrough" in treating small cell lung cancer

(Alliance News) - AstraZeneca PLC on Friday reported positive results relating to its Imfinzi cancer treatment in phase III trials.

Read more
5 Apr 2024 07:50

LONDON BRIEFING: Shell to book USD600 million first-quarter write-off

(Alliance News) - London's FTSE 100 is called to open lower on Friday, with hawkish remarks from Federal Reserve policymakers and fears of ratcheting Middle East tensions giving investors little to cheer about ahead of the latest US jobs data.

Read more
5 Apr 2024 07:23

AstraZeneca announces positive lung cancer treatment trial results

(Sharecast News) - AstraZeneca announced positive high-level results from a phase three trial demonstrating significant advancements in the treatment of limited-stage small cell lung cancer (LS-SCLC) on Friday.

Read more
4 Apr 2024 13:09

UK shareholder meetings calendar - next 7 days

Friday 5 April 
Faron Pharmaceuticals LtdAGM
VPC Specialty Lending Investments PLCGM re capital return via B share scheme
Monday 8 April 
Premier African Minerals LtdAGM
Tuesday 9 April 
Ethernity Networks LtdEGM re board appointments and option grants
Wednesday 10 April 
Valereum PLCAGM
Wincanton PLCGM re takeover by GXO Logistics Inc
Thursday 11 April 
AstraZeneca PLCAGM
  
Comments and questions to newsroom@alliancenews.com
  
A full 21-day events calendar is provided each day with a subscription to Alliance News UK Professional.
  
Copyright 2024 Alliance News Ltd. All Rights Reserved.

Read more
3 Apr 2024 22:01

Biden, Senator Bernie Sanders push companies to cut cost of asthma inhalers, prescription drugs

WASHINGTON, April 3 (Reuters) - President Joe Biden hosted a White House event with U.S. Senator Bernie Sanders on Wednesday to tout their fight against high prescription drug prices and push companies to cut the cost of inhalers for asthma sufferers.

Read more
3 Apr 2024 17:22

UK's FTSE 100 pressured by stronger pound; miners climb

FTSE 100 flat, FTSE 250 up 0.2%

*

Read more
3 Apr 2024 11:02

CORRECT: AstraZeneca, Daiichi make US progress with licence approvals

(Correcting the description of extravascular haemolysis' effects on patients with paroxysmal nocturnal haemoglobinuria)

Read more
2 Apr 2024 15:22

London close: Stocks turn red on return from Easter break

(Sharecast News) - UK stocks experienced a downturn by the end of trading on Tuesday, as investors resumed activity following the extended weekend, with initial gains reversed by the close ahead of a week marked by a number of key economic data releases.

Read more
2 Apr 2024 11:50

LONDON MARKET MIDDAY: FTSE 100 buoyed by UK manufacturing growth

(Alliance News) - The FTSE 100 in London was up at midday on Tuesday, reacting to the UK manufacturing sector returning growth and further PMI data across the globe.

Read more
2 Apr 2024 10:25

AstraZeneca and Daiichi make US progress with latest licence approvals

(Alliance News) - AstraZeneca PLC on Tuesday noted significant progress for two of its clinical-stage treatments in the US.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.